MORRISVILLE, N.C.--(BUSINESS WIRE)--etrials® Worldwide, Inc. (Nasdaq: ETWC, ETWCW, ETWCU), a leading provider of eClinical software and services that optimize clinical-trial management and accelerate time to market, today announced a partnership between Roche Diagnostics’ ACCU-CHEK blood glucose meters and etrials’ eDiary solution. With this partnership, patients with diabetes participating in clinical trials can now seamlessly transmit vital glucose meter data into the etrials eDiary solution using wireless infrared ports located on both devices.
